Clinical Trials Directory

Trials / Completed

CompletedNCT00588211

Measurement of Cancer-Related Risk Perception in Smokers

Status
Completed
Phase
Study type
Observational
Enrollment
1,514 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

Detailed description

The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

Conditions

Interventions

TypeNameDescription
BEHAVIORALInterviews45-minute individual interviews after the conclusion of their dental appointment
BEHAVIORALfocus groupA focus group of the preliminary cancer-related risk perception item pool.
BEHAVIORALSurveyQuantitative item analysis of the final item pool.
BEHAVIORALSurveyA second confirmatory factor analysis.

Timeline

Start date
2001-09-01
Primary completion
2022-09-13
Completion
2022-09-13
First posted
2008-01-08
Last updated
2022-09-16

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00588211. Inclusion in this directory is not an endorsement.